Prolonged functional optical sensitivity in non-human primate motor nerves following cyclosporine-based immunosuppression and rAAV2-retro mediated expression of ChR2
- 1 March 2019
- conference paper
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 534-537
Abstract
Peripheral optogenetic stimulation of motor activity offers enticing advantages over traditional functional electrical stimulation for the purposes of reanimating paralyzed muscles. When facilitated by intramuscular injection of viral gene therapy constructs, however, the process of transducing light sensitive ion channels along motor nerves faces several challenges including uptake of the virus at the neuromuscular junction as well as evasion of both virus and expressed gene products from the immune system. These hurdles to successful peripheral motor gene therapy are often amplified when attempting to translate these techniques to non-human primates. In this study, we examined the efficacy of a systemic immunosuppression regimen and use of a designer adeno-associated virus in prolonging functional opsin expression in targeted peripheral nerves of a macaque. Using a regimen of daily cyclosporine and either an intramuscular or intraneural injection of an rAAV2-retro based vector, we observed functional nerve expression of ChR2 via EMG activity locked to optical stimulation of a targeted nerve for up to 24 weeks post-injection. Throughout this experiment, we observed a gross timeline of expression including an initial increase of ChR2 expression over 9-13 weeks followed by an eventual decline after cessation of the immunosuppression regimen. These results suggest a potential strategy for successful translation of peripheral motor gene therapy to human subjects.Keywords
This publication has 12 references indexed in Scilit:
- A Designer AAV Variant Permits Efficient Retrograde Access to Projection NeuronsNeuron, 2016
- Optical Control of Muscle Function by Transplantation of Stem Cell–Derived Motor Neurons in MiceScience, 2014
- AAV9-mediated Expression of a Non-self Protein in Nonhuman Primate Central Nervous System Triggers Widespread Neuroinflammation Driven by Antigen-presenting Cell TransductionMolecular Therapy, 2014
- Optogenetic Control of Targeted Peripheral Axons in Freely Moving AnimalsPLOS ONE, 2013
- Successful Regional Delivery and Long-term Expression of a Dystrophin Gene in Canine Muscular Dystrophy: A Preclinical Model for Human TherapiesMolecular Therapy, 2012
- A Simplified Immune Suppression Scheme Leads to Persistent Micro-dystrophin Expression in Duchenne Muscular Dystrophy DogsHuman Gene Therapy, 2012
- Orderly recruitment of motor units under optical control in vivoNature Medicine, 2010
- Efficient transduction of non-human primate motor neurons after intramuscular delivery of recombinant AAV serotype 6Gene Therapy, 2009
- Recombinant Adeno-Associated Virus Serotype 6 (rAAV2/6)-Mediated Gene Transfer to Nociceptive Neurons through Different Routes of DeliveryMolecular Pain, 2009
- Effects of transient immunosuppression on adenoassociated, virus-mediated, liver-directed gene transfer in rhesus macaques and implications for human gene therapyBlood, 2006